The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
Abstract
G protein–coupled receptors (GPCRs) are an evolutionarily conserved family of signaling molecules comprising approximately 2% of the human genome; this receptor family remains a central focus in basic pharmacology studies and drug discovery efforts. Detailed studies of drug action at GPCRs over the past decade have revealed existing and novel ligands that exhibit polypharmacology—that is, drugs with activity at more than one receptor target for which they were designed. These “off-target” drug actions can be a liability that causes adverse side effects; however, in several cases, drugs with less selectivity demonstrate better clinical efficacy. Here we review physical screening and cheminformatic approaches that define drug activity at the GPCR receptorome. In many cases, such profiling has revealed unexpected targets that explain therapeutic actions as well as off-targets underlying drug side effects. Such drug-receptor profiling has also provided new insights into mechanisms of action of existing drugs and has suggested directions for future drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most clinically effective antipsychotics also exhibit a myriad of other actions that contribute to both therapeutic and side-effect profiles [359,360].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [359]
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Self-citation
Research works printed but not linked: 4
- Alouani S, 2000, Methods Mol. Biol., 138, 135
- Stewart GD, 2010, Am. Chem. Soc. Chem. Biol., 5, 365
- Ozawa A, 2010, Am. Assoc. Pharm. Sci. J., 12, 378
- Hippius H., 1999, J. Clin. Psychiatry, 60, 22
Cited by
Sorted by citations
Items 101–200 of 221
Paoletta, S., Tosh, D. K., Salvemini, D., & Jacobson, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097858 · Cited by 25
Johansson, H., Boesgaard, M. W., Nørskov-Lauritsen, L., Larsen, I., Kuhne, S., Gloriam, D. E. I., Bräuner‐Osborne, H., & Pedersen, D. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01254 · Cited by 25
Prosser, R. S., Ye, L., Pandey, A. N., & Orazietti, A. P. (2017) · BioEssays · doi:10.1002/bies.201700072 · Cited by 26
Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
Tagliazucchi, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.812227 · Cited by 25
Klein, M. T., Dukat, M., Glennon, R. A., & Teitler, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179606 · Cited by 24
Kato, A., & Witkin, J. M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.09.015 · Cited by 22
Predicting GPCR Promiscuity Using Binding Site Features
Levit, A., Beuming, T., Krilov, G., Sherman, W., & Niv, M. Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400552z · Cited by 22
Manzoni, L., Belvisi, L., Bianchi, A., Conti, A., Drago, C., Matteo, M. D., Ferrante, L., Mastrangelo, E., Perego, P., Potenza, D., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.020 · Cited by 20
Li, N., Yang, M.-Y., Zhang, M., Liu, N., Zhou, A.-W., Chai, Z., & Lu, S. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01603-w · Cited by 19
Zhang, H., Lin, Y., Zhuang, M., Zhu, L., Dai, Y., & Lin, M. (2022) · Gene · doi:10.1016/j.gene.2022.146961 · Cited by 19
Structure-based virtual screening discovers potent and selective adenosine A1 receptor antagonists
Matricon, P. G., Nguyen, A. T. N., Vo, D. D., Baltos, J., Jaiteh, M., Luttens, A., Kampen, S., Christopoulos, A., Kihlberg, J. O., May, L. T., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115419 · Cited by 19
Covalent conjugation of oligonucleotides with cell-targeting ligands
Alam, M. R., Ming, X., Nakagawa, O., Jin, J., & Juliano, R. L. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.037 · Cited by 19
Controlling absence seizures from the cerebellar nuclei via activation of the Gq signaling pathway
Schwitalla, J. C., Pakusch, J., Mücher, B., Brückner, A., Depke, D. A., Fenzl, T., Zeeuw, C. I. D., Kros, L., Hoebeek, F. E., & Mark, M. D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04221-5 · Cited by 18
Studies of a ubiquitous receptor family
Roth, B. L., & Marshall, F. H. (2012) · Nature · doi:10.1038/492057a · Cited by 18
Self-citationSpatiotemporal Control of GPR37 Signaling and Its Behavioral Effects by Optogenetics
Zheng, W., Zhou, J., Luan, Y., Yang, J., Ge, Y., Wang, M., Wu, B., Wu, Z., Chen, X., Li, F. Y., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00095 · Cited by 18
Aldrin-Kirk, P., & Björklund, T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9065-8_4 · Cited by 20
Activity Map and Transition Pathways of G Protein-Coupled Receptor Revealed by Machine Learning
Mollaei, P., & Farimani, A. B. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00032 · Cited by 17
Tian, W., & Chen, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.616820 · Cited by 19
Gaiser, B. I., Danielsen, M., Märcher-Rørsted, E., Jørgensen, K. R., Wróbel, T. M., Frykman, M., Johansson, H., Bräuner‐Osborne, H., Gloriam, D. E. I., Mathiesen, J. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00595 · Cited by 18
Sun, Y., Hasbi, A., & George, S. R. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080727 · Cited by 18
Split Luciferase Complementation for Analysis of Intracellular Signaling
Hattori, M., & Ozawa, T. (2014) · Analytical Sciences · doi:10.2116/analsci.30.539 · Cited by 16
Opportunities and challenges in drug discovery targeting the orphan receptor GPR12
Wang, P., Lv, L., Li, H., Wang, C., & Zhou, J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103698 · Cited by 14
Okude, J., Ueda, T., Kofuku, Y., Sato, M., Nobuyama, N., Kondo, K., Shiraishi, Y., Mizumura, T., Onishi, K., Natsume, M., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201508794 · Cited by 14
Binding sites in membrane proteins – Diversity, druggability and prospects
Adams, R. A., Worth, C. L., Günther, S., Dunkel, M., Lehmann, R., & Preißner, R. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.06.003 · Cited by 17
Interaction of Membrane Cholesterol with GPCRs: Implications in Receptor Oligomerization
Sengupta, D., Kumar, G. A., & Chattopadhyay, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_16 · Cited by 14
Fatakia, S., Sarkar, P., & Chattopadhyay, A. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.02.010 · Cited by 13
Iyer, P., Dimova, D., Vogt, M., & Bajorath, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3002765 · Cited by 13
Selvam, B., Porter, S. L., & Tikhonova, I. G. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400282q · Cited by 13
Roelse, M., de Ruijter, N. C. A., Vrouwe, E. X., & Jongsma, M. A. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.03.065 · Cited by 13
Babwah, A. V. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110886 · Cited by 12
Владимирович, С. А., Barmasov, A. V., & Brown, M. F. (2015) · Optics and Spectroscopy · doi:10.1134/s0030400x15050240 · Cited by 12
Kim, S. T., Doukmak, E. J., Flax, R. G., Gray, D. J., Zirimu, V., de Jong, E. P., & Steinhardt, R. C. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00544 · Cited by 11
Schüß, C., Vu, O., Mishra, N. M., Tough, I. R., Du, Y., Stichel, J., Cox, H. M., Weaver, C. D., Meiler, J., Emmitte, K. A., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00383 · Cited by 13
Bitopic Ligands Support the Presence of a Metastable Binding Site at the β2 Adrenergic Receptor
Gaiser, B. I., Danielsen, M., Xu, X., Jørgensen, K. R., Fronik, P., Märcher-Rørsted, E., Wróbel, T. M., Liu, X., Mathiesen, J. M., & Pedersen, D. S. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00578 · Cited by 11
Historeceptomic Fingerprints for Drug-Like Compounds
Shmelkov, E., Grigoryan, A., Swetnam, J., Xin, J., Tivon, D., Shmelkov, S. V., & Cardozo, T. J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00371 · Cited by 11
Cell-Based Assays and Animal Models for GPCR Drug Screening
Takakura, H., Hattori, M., Tanaka, M., & Ozawa, T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2336-6_18 · Cited by 11
Gao, N., Liang, T., Yuan, Y., Xiao, X., Zhao, Y., Guo, Y., Li, M., & Pu, X. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp03710k · Cited by 11
GPCR profiling: from hits to leads and from genotype to phenotype
Cvijic, M. E., Sum, C. S., Alt, A. J., & Zhang, L. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.10.005 · Cited by 10
Viral Vector Delivery of DREADDs for CNS Therapy
Pickering, C. A., & Mazarakis, N. D. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210211102435 · Cited by 11
Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure
Dhalla, N. S., Bhullar, S. K., Adameová, A., Mota, K. O., & de Vasconcelos, C. M. L. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409264 · Cited by 9
Chemogenetic approaches to unravel circuit wiring and related behavior after spinal cord injury
Steenbergen, V. V., & Bareyre, F. M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113839 · Cited by 8
A piggyBac-based TANGO GFP assay for high throughput screening of GPCR ligands in live cells
Li, F., Jiang, X., Luo, L.-L., Xu, Y.-M., Huang, X., Huang, C., & Zhang, Y. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0359-x · Cited by 9
Designed dualsteric modulators: A novel route for drug discovery
Li, N., Zheng, G., Fu, L., Liu, N., Chen, T., & Lu, S. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104141 · Cited by 8
Guo, C., Ye, J., Liu, J., Li, Z., Deng, M., Guo, Y., Liu, G., Sun, B., Li, Y., & Liu, D. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1420164 · Cited by 8
Yao, T., Luo, J., Han, X., Yi, H., Zhang, H., Pan, W., Xue, Q., Liu, X., Fu, J., & Zhang, A. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c02014 · Cited by 8
Functional Characterization of Sodium Channel Inhibitors at the Delta-Opioid Receptor
Mohamud, A. O., Zeghal, M., Patel, S., Laroche, G., Blgacim, N., & Giguère, P. M. (2022) · ACS Omega · doi:10.1021/acsomega.1c07226 · Cited by 8
Targeting the diuretic hormone receptor to control the cotton leafworm, Spodoptera littoralis
Apone, F., Ruggiero, A., Tortora, A., Tito, A., Grimaldi, M. R., Arciello, S., Andrenacci, D., Lelio, I. D., & Colucci, G. (2014) · Journal of Insect Science · doi:10.1093/jis/14.1.87 · Cited by 8
Wang, H., Li, R., Xi, X., Meng, T., Zhou, M., Wang, L., Zhang, Y., Chen, T., & Shaw, C. (2013) · Amino Acids · doi:10.1007/s00726-013-1470-8 · Cited by 8
Pandey, A. N., Sarker, M., Liu, X., & Rainey, J. K. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0009 · Cited by 9
Impossible or Merely Difficult? Two Grand Challenges from a Biologist’s Perspective
Roth, B. L. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000386 · Cited by 8
Self-citationTan, Y., & Pang, X. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.043 · Cited by 8
GPCR Allostery: A View from Computational Biology
Li, M., Bao, Y., Li, M., & Guo, J. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230113125246 · Cited by 7
Cao, Z., Yan, L., Shen, Z., Chen, Y., Shi, Y., He, X., & Zhou, N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118718 · Cited by 7
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro
Orr‐Burks, N., Murray, J., Todd, K. V., Bakre, A. A., & Tripp, R. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259129 · Cited by 7
Drug–Target Interaction Prediction Based on an Interactive Inference Network
Chen, Y., Liang, X., Du, W., Liang, Y., Wong, G., & Chen, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147753 · Cited by 6
Therapeutic Potential of Functional Selectivity in the Treatment of Heart Failure
Christensen, G. L., Aplin, M., & Hansen, J. L. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2011.11.005 · Cited by 6
Predictive Modeling of Tox21 Data
Huang, R. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-16443-0_14 · Cited by 6
Segregation of nascent GPCRs in the ER-to-Golgi transport by CCHCR1 via direct interaction
Xu, X., Qiu, L., Zhang, M., & Wu, G. (2024) · Journal of Cell Science · doi:10.1242/jcs.261685 · Cited by 7
Structural diversity in ligand recognition by GPCRs
Jakowiecki, J., Miszta, P., Niewieczerzał, S., & Filipek, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00003-9 · Cited by 6
3D-QSAR and Molecular Docking Studies of Novel GPR52 Agonists
Gu, Q., Hou, J., Gao, H., Shi, M., Zhuang, Y., Wu, Q., & Zheng, L. (2023) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416523500308 · Cited by 6
Chauhan, A., Singh, J., Sangwan, N., Dhawan, R., & Avti, P. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01143-2 · Cited by 6
Multiplexed Lipid Bilayers on Silica Microspheres for Analytical Screening Applications
Oropeza, N. F., Zurek, N. A., Cruz, M. G. L., Fabry‐Wood, A., Fetzer, J. M., Graves, S. W., & Shreve, A. P. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00296 · Cited by 7
Srivastava, S. K., Ramaneti, R., Roelse, M., Tong, H. D., Vrouwe, E. X., Brinkman, A. G. M., de Smet, L. C. P. M., van Rijn, C. J. M., & Jongsma, M. A. (2015) · RSC Advances · doi:10.1039/c5ra04976h · Cited by 6
Modeling of Compound Profiling Experiments Using Support Vector Machines
Balfer, J., Heikamp, K., Laufer, S., & Bajorath, J. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12294 · Cited by 7
Molecular Dynamics and Machine Learning Study of Adrenaline Dynamics in the Binding Pocket of GPCR
Seshadri, K., & Krishnan, M. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00401 · Cited by 5
Intracellular Loop 2 Peptides of the Human 5HT1a Receptor are Differential Activators of Gi
Hall, B., Squires, C., & Parker, K. (2012) · International Journal of Peptides · doi:10.1155/2012/490734 · Cited by 5
Strategies for Studying the Ligand Binding Site of GPCRs
Couvineau, A., Tan, Y., Ceraudo, E., & Laburthe, M. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391861-1.00010-1 · Cited by 5
Gut metabolites: make orphans adopted
Zhang, W., & Zhu, S. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz012 · Cited by 5
Jin, P., Ren, Z., Ye, F., & Ying, W. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2013.12.036 · Cited by 5
Opsin expression varies across larval development and taxa in pteriomorphian bivalves
Hasan, M. S., McElroy, K. E., Audino, J. A., & Serb, J. M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1357873 · Cited by 4
Targeting the Diuretic Hormone Receptor to Control the Cotton Leafworm,Spodoptera littoralis
Apone, F., Ruggiero, A., Tortora, A., Tito, A., Grimaldi, M. R., Arciello, S., Andrenacci, D., Lelio, I. D., & Colucci, G. (2014) · Journal of Insect Science · doi:10.1673/031.014.87 · Cited by 4
Application of Biomolecular Simulations to G Protein–Coupled Receptors ( GPCRs )
Torrens‐Fontanals, M., Stępniewski, T. M., Rodríguez‐Espigares, I., & Selent, J. (2018) · Methods and principles in medicinal chemistry · doi:10.1002/9783527806836.ch8 · Cited by 4
Steric control of signaling bias in the immunometabolic receptor GPR84
Wang, P., Zhang, X., Guseinov, A. A., Jenkins, L., von Hallerstein, C., Colburn, J. D., Ives, R., Luscombe, V. B., Marsango, S., Oktavia, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77312-7 · Cited by 3
Dopamine receptor divergence revealed using a common ligand
Sibley, D. R., Nilson, A. N., Moritz, A. E., & Shi, L. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.002 · Cited by 3
GPR97 deficiency suppresses Wnt/β‐catenin signaling in hypertensive nephropathy
Gao, P., Zhu, J., Xiangyun, G., Li, J., & Wu, J. (2024) · The FASEB Journal · doi:10.1096/fj.202302298r · Cited by 3
Wang, M., Fu, X., Du, L., Shi, F., Huang, Z., & Yang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158389 · Cited by 3
Lipina, T. V., Giang, H., Thacker, J. S., Wetsel, W. C., Caron, M. G., Beaulieu, J., Salahpour, A., & Ramsey, A. J. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae060 · Cited by 3
Quantifying GPCR Internalization: A Focus on the Kisspeptin Receptor
Pampillo, M., & Babwah, A. V. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2336-6_9 · Cited by 3
Polypharmacology and Adverse Bioactivity Profiles Predict Potential Toxicity and Drug‐Related Adrs
Kaserer, T., Temml, V., & Schuster, D. (2014) · doi:10.1002/9781118783344.ch2 · Cited by 3
Computational Strategies to Incorporate GPCR Complexity in Drug Design
Martí-Solano, M., Kaczor, A. A., Guixà-González, R., & Selent, J. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.1016/b978-1-60805-865-5.50001-0 · Cited by 2
Compound Structure‐Independent Activity Prediction in High‐Dimensional Target Space
Balfer, J., Hu, Y., & Bajorath, J. (2014) · Molecular Informatics · doi:10.1002/minf.201400051 · Cited by 2
Hattori, M., & Ozawa, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3813-1_16 · Cited by 2
Majumdar, J. R., Grbic, J., Carlsson, S., Barreiro, D., Marte, M., Laudone, V. P., Assel, M. J., & Masson, G. (2024) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2023.11.007 · Cited by 2
Computational design of allosteric pathways reprograms ligand-selective GPCR signalingPreprint
Hijazi, M., Kéri, D., Oggier, A., Sengar, A., Agosto, M. A., Wensel, T. G., & Barth, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.13.670154 · Cited by 3
Peptide ligand discovery of G protein-coupled receptors
Hermes, J., Matic, M., Yeung, H. Y., Jiang, Q., Urvas, L., Korchevaya, E., Stępniewski, T. M., Murza, A., Selent, J., Freissmuth, M., et al. (2026) · Nature Reviews Methods Primers · doi:10.1038/s43586-026-00503-5 · Cited by 1
Chemoinformatic Approaches to Target Identification
Gregori‐Puigjané, E., & Keiser, M. J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00050 · Cited by 1
Quantitative analysis of G-protein-coupled receptor internalization using DnaE intein-based assay
Lu, B., Chen, L., Zhang, Y., Shi, Y., & Zhou, N. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2015.10.006 · Cited by 1
Pandey, A. N. (2018) · DalSpace (Dalhousie University) · Cited by 1
Huynh, N. C., Ibrahim, B. A., Lee, C. M., Key, M. N., & Llano, D. A. (2019) · Neuromethods · doi:10.1007/978-1-4939-9944-6_2 · Cited by 1
Zamolodchikova, T. S., Tolpygo, S. M., & Kotov, A. V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.772217 · Cited by 1
Roth, B. L., Gotoh, Y., Giguère, P. M., & Nichols, D. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/251769 · Cited by 1
Self-citationReceptomics, design of a microfluidic receptor screening technology
Roelse, M. (2019) · doi:10.18174/498013 · Cited by 1
Nie, Y., Yang, J., Liang, J., Yang, Z., Zhou, L., Liu, Y., Ma, X., Qian, Z., Hong, P., Kalueff, A. V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-685780/v1 · Cited by 1
British Pharmacological Society, 5th Focused Meeting on Cell Signalling: Matters arising …
Willars, G. B., Tobin, A. B., & Challiss, R. A. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13171
Multiplexed cell-based assays to profile GPCR activities and cellular signalling
Galinski, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5570
Inference of binding affinity from neuronal receptors in humans
de Jesus, A. S. G. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Pharmacosynthetics and the Cell-Type-Specific Control of Neuronal Signaling
Farrell, M. S. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/e90f-e611
Weaver, A. D. (2017) · Leicester Research Archive (University of Leicester)
Curado, T. F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-13062017-162234
Metadata
- Authors
- Allen, J. A., & Roth, B. L.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2011-02-10
- Volume
- 51
- Issue
- 1
- Pages
- 117-144
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2160203886
- Cited by
- 216
- References
- 145
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 16 · 2023: 12 · 2022: 15 · 2021: 7 · 2020: 10 · 2019: 15 · 2018: 15 · 2017: 14 · 2016: 10 · 2015: 22 · 2014: 21 · 2013: 22 · 2012: 17
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (HHSN-271-2008-00025-C)
- National Institute of Mental Health (U19MH082441, R01MH061887)
- National Institute on Drug Abuse (R01DA017204)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD040127)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- G protein-coupled receptors, polypharmacology, cheminformatics, adverse drug reactions, receptor selectivity, mechanisms of drug action, drug development
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Ligands, Drug Design, Drug Delivery Systems, Computational Biology, Receptors, G-Protein-Coupled, Drug Discovery, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review